Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism

Cody J. Billsa Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information

Hongjie Xiaa Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information

John Yun-Chung Chena Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information

Jason Yeunga Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information

Birte K. Kalverama Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA;b Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USAView further author information

David Walkerc Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA;d Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USAView further author information

Xuping Xiea Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA;e Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information

Pei-Yong Shia Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA;e Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX, USA;f Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA;g Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA;h Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA;i Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information

show all

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date